CalciMedica (CALC) Institutional Ownership $3.69 -0.51 (-12.14%) Closing price 04:00 PM EasternExtended Trading$3.90 +0.22 (+5.83%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for CalciMedica (NASDAQ:CALC)Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$5.10MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$222.67K Get CALC Insider Trade Alerts Want to know when executives and insiders are buying or selling CalciMedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALC Institutional Buying and Selling by Quarter CalciMedica Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025First Manhattan CO. LLC.13,226$25K0.0%N/A0.095% 5/14/2025Stonepine Capital Management LLC367,371$702K0.7%-21.6%2.629% 5/13/2025Wealthedge Investment Advisors LLC108,291$207K0.1%+289.3%0.775% 4/22/2025Cambridge Investment Research Advisors Inc.23,539$45K0.0%N/A0.175% 4/9/2025180 Wealth Advisors LLC16,400$31K0.0%N/A0.122% 3/12/2025Wealthedge Investment Advisors LLC27,819$98K0.0%N/A0.206% 2/17/2025Stonepine Capital Management LLC468,793$1.66M1.3%N/A3.478% 2/17/2025Millennium Management LLC72,057$255K0.0%+30.5%0.535% 2/17/2025Deerfield Management Company L.P. Series C1,300,000$4.60M0.1%+30.0%9.644% 2/17/2025Cetera Investment Advisers16,873$60K0.0%+37.1%0.125% Get the Latest News and Ratings for CALC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Alyeska Investment Group L.P.372,256$1.32M0.0%N/A2.762% 2/13/2025Renaissance Technologies LLC43,200$153K0.0%N/A0.320% 2/12/2025Geode Capital Management LLC90,866$322K0.0%+36.5%0.674% 2/10/2025Corient Private Wealth LLC38,000$135K0.0%N/A0.282% 2/6/2025Atria Investments Inc34,012$120K0.0%+28.3%0.252% 11/25/2024PVG Asset Management Corp15,115$67K0.3%N/A0.112% 11/16/2024Geode Capital Management LLC66,553$295K0.0%+51.2%0.619% 11/5/2024BML Capital Management LLC153,887$682K0.4%-4.1%1.432% 11/1/2024Atria Investments Inc26,503$117K0.0%+136.5%0.247% 4/23/2024BML Capital Management LLC160,424$667K0.4%+10.3%1.494% 2/2/2024Meritage Portfolio Management46,000$132K0.0%+360.0%0.810% 1/30/2024BML Capital Management LLC145,424$416K0.3%+63.8%2.560% 12/7/2023Hudson Bay Capital Management LP166,857$432K0.0%N/A2.938% 7/31/2023Meritage Portfolio Management10,000$40K0.0%N/A0.177% 7/24/2023BML Capital Management LLC88,781$356K0.3%N/A1.568% (Data available from 1/1/2016 forward) CALC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALC shares? During the previous two years, 17 institutional investors and hedge funds held shares of CalciMedica. The most heavily invested institutionals were Deerfield Management Company L.P. Series C ($4.60M), Alyeska Investment Group L.P. ($1.32M), Stonepine Capital Management LLC ($702K), BML Capital Management LLC ($682K), Hudson Bay Capital Management LP ($432K), Geode Capital Management LLC ($322K), and Millennium Management LLC ($255K).Learn more on CalciMedica's institutional investors. Which institutional investors have been buying CalciMedica's stock? Of the 17 institutional investors that purchased CalciMedica's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Stonepine Capital Management LLC ($468.79K), Alyeska Investment Group L.P. ($372.26K), Deerfield Management Company L.P. Series C ($300K), Hudson Bay Capital Management LP ($166.86K), BML Capital Management LLC ($160.42K), Wealthedge Investment Advisors LLC ($108.29K), and Geode Capital Management LLC ($46.84K). How much institutional buying is happening at CalciMedica? Institutional investors have bought a total of 1,489,853 shares in the last 24 months. This purchase volume represents approximately $5.10M in transactions. Which of CalciMedica's major shareholders have been selling company stock? The following institutional investors have sold CalciMedica stock in the last 24 months: Stonepine Capital Management LLC ($101.42K), and BML Capital Management LLC ($6.54K). How much institutional selling is happening at CalciMedica? Institutional investors have sold a total of 107,959 shares in the last 24 months. This volume of shares sold represents approximately $222.67K in transactions. Related Companies IO Biotech Major Shareholders Protara Therapeutics Major Shareholders Cellectis Major Shareholders BioHarvest Sciences Major Shareholders Skye Bioscience Major Shareholders Tenaya Therapeutics Major Shareholders MiNK Therapeutics Major Shareholders Protalix BioTherapeutics Major Shareholders Oncolytics Biotech Major Shareholders Cardiol Therapeutics Major Shareholders This page (NASDAQ:CALC) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
